Short-time interruption of second-line mycophenolate treatment in a patient with renal sarcoidosis enabled a marked antibody response to SARS-CoV-2 messenger RNA vaccine.
Peter SchnuelleSebastian KöllingAlexander MüllerWilhelm H SchmittPublished in: Clinical kidney journal (2021)